Parkinson's Disease Research

Parkinson's disease (PD) is a degenerative disease of the central nervous system that often impairs motor skills, speech, and other functions. Symptoms of the disease include resting tremor, bradykinesia and rigidity. The primary symptoms are the result of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Symptoms of the disease appear once 50-80% of dopamine neurons have died. Parkinson's disease is both chronic and progressive.

Parkinson's Disease Research Products Targets

Products for Parkinson's Disease Research - Page 29

  1. Cat.No. Product Name Information/Activity
  2. BCC7628 Rec 15/2615 dihydrochloride 173059-17-1 Rec 15/2615 dihydrochloride chemical structure
  3. BCC5741 RS 100329 hydrochloride 1215654-26-4 RS 100329 hydrochloride chemical structure
  4. BCC6874 RS 17053 hydrochloride RS 17053 hydrochloride is a potent and selective α1A adrenoceptor antagonist, with a pKi value of 9.1 in native cell membrane and a pA2 value of 9.8 in functional assays. RS 17053 hydrochloride chemical structure
  5. BCC7350 SNAP 5089 157066-77-8 SNAP 5089 chemical structure
  6. BCC5044 Urapidil HCl Urapidil HCl is an α1-adrenoceptor antagonist and 5-HT1A receptor agonist. Urapidil HCl chemical structure
  7. BCC6858 WB 4101 hydrochloride 2170-58-3 WB 4101 hydrochloride chemical structure
  8. BCC6883 AH 11110 hydrochloride 179388-65-9 AH 11110 hydrochloride chemical structure
  9. BCC6705 3-MPPI 133399-65-2 3-MPPI chemical structure
  10. BCC1417 B-HT 920 Talipexole dihydrochloride (B-HT 920 dihydrochloride) is a dopamine D2 receptor agonist, α2-adrenoceptor agonist and 5-HT3 receptor antagonist, which displays antiParkinsonian activity. B-HT 920 chemical structure
  11. BCC7474 B-HT 933 dihydrochloride 36067-72-8 B-HT 933 dihydrochloride chemical structure

Items 281 to 290 of 752 total